## AAP Phototherapy Nomogram for Neonatal Jaundice **Key Point:** The AAP phototherapy threshold depends on **postnatal age in hours** and **risk category** (low, medium, high risk). For healthy term infants (≥38 weeks, low risk), thresholds rise progressively with age after the nadir at 72–96 hours. ### Risk Stratification The AAP classifies neonates into three risk categories: | Risk Category | Definition | | --- | --- | | **Low risk** | ≥38 weeks gestation AND well | | **Medium risk** | ≥38 weeks gestation WITH risk factors (isoimmune hemolytic disease, G6PD deficiency, asphyxia, significant lethargy, temperature instability, sepsis, acidosis) OR 35–37⁶/₇ weeks AND well | | **High risk** | 35–37⁶/₇ weeks AND risk factors | ### Phototherapy Thresholds — Healthy Term Infant (≥38 weeks, Low Risk) | Postnatal Age | Phototherapy Threshold | | --- | --- | | **24 hours** | ≥12 mg/dL | | **48 hours** | ≥15 mg/dL | | **72 hours** | ≥17 mg/dL | | **96 hours** | **≥18 mg/dL** | | **≥120 hours** | ≥20 mg/dL | **High-Yield:** At **96 hours (4 days)**, the phototherapy threshold for a healthy term infant (≥38 weeks, low risk) is **≥18 mg/dL** per the AAP 2004/2009 clinical practice guideline nomogram. The threshold rises with increasing postnatal age because the risk of bilirubin encephalopathy decreases as the infant matures and the blood-brain barrier becomes less permeable to bilirubin. **Clinical Pearl:** The thresholds are **lowest at younger ages** (24–48 hours) because early-onset hyperbilirubinemia is more likely to be pathological (hemolytic disease, sepsis). By 96 hours, physiological jaundice is peaking and the threshold is appropriately higher at ≥18 mg/dL for low-risk term infants. Infants with risk factors (prematurity, hemolysis, sepsis) have **lower thresholds** at each age. ### When to Treat - **Phototherapy** is indicated when TSB ≥ nomogram threshold for age and risk category - **Exchange transfusion** is indicated when TSB exceeds the exchange threshold (typically ≥25 mg/dL for healthy term infants at 96 hours) - **Intensive phototherapy** (multiple lights, intensive monitoring) is used for infants at high risk of bilirubin neurotoxicity [cite: American Academy of Pediatrics Clinical Practice Guideline — Management of Hyperbilirubinemia in the Newborn Infant ≥35 Weeks of Gestation, Pediatrics 2004; Nelson Textbook of Pediatrics 21e Ch 102] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.